Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк., Те Риджентс Оф Те Юниверсити Оф КалифорнияfiledCriticalПфайзер Инк.
Priority claimed from PCT/US2019/023883external-prioritypatent/WO2019190984A1/en
Publication of EA202092327A1publicationCriticalpatent/EA202092327A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Изобретение относится к молекулам полипептида LFA3, например вариантным молекулам гибридного полипептида LFA3. Изобретение включает применение и ассоциированные способы применения молекул полипептида LFA3.The invention relates to LFA3 polypeptide molecules, eg, variant LFA3 fusion polypeptide molecules. The invention includes the use and associated methods of using LFA3 polypeptide molecules.
EA202092327A2018-12-212019-03-25
LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS
EA202092327A1
(en)